Gene expression signatures for prognosis in NSCLC, coupled with signatures of oncogenic pathway deregulation, provide a novel approach for selection of molecular targets.
Publication
, Conference
Petersen, RP; Bild, A; Dressman, H; Joshi, MBM; Conlon, DH; West, M; Nevins, JR; Harpole, DH
Published in: JOURNAL OF CLINICAL ONCOLOGY
June 1, 2005
Duke Scholars
Published In
JOURNAL OF CLINICAL ONCOLOGY
EISSN
1527-7755
ISSN
0732-183X
Publication Date
June 1, 2005
Volume
23
Issue
16
Start / End Page
626S / 626S
Location
Orlando, FL
Publisher
AMER SOC CLINICAL ONCOLOGY
Conference Name
41st Annual Meeting of the American-Society-of-Clinical-Oncology
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Petersen, R. P., Bild, A., Dressman, H., Joshi, M. B. M., Conlon, D. H., West, M., … Harpole, D. H. (2005). Gene expression signatures for prognosis in NSCLC, coupled with signatures of oncogenic pathway deregulation, provide a novel approach for selection of molecular targets. In JOURNAL OF CLINICAL ONCOLOGY (Vol. 23, pp. 626S-626S). Orlando, FL: AMER SOC CLINICAL ONCOLOGY.
Petersen, R. P., A. Bild, H. Dressman, M. B. M. Joshi, D. H. Conlon, M. West, J. R. Nevins, and D. H. Harpole. “Gene expression signatures for prognosis in NSCLC, coupled with signatures of oncogenic pathway deregulation, provide a novel approach for selection of molecular targets.” In JOURNAL OF CLINICAL ONCOLOGY, 23:626S-626S. AMER SOC CLINICAL ONCOLOGY, 2005.
Petersen RP, Bild A, Dressman H, Joshi MBM, Conlon DH, West M, et al. Gene expression signatures for prognosis in NSCLC, coupled with signatures of oncogenic pathway deregulation, provide a novel approach for selection of molecular targets. In: JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY; 2005. p. 626S-626S.
Petersen, R. P., et al. “Gene expression signatures for prognosis in NSCLC, coupled with signatures of oncogenic pathway deregulation, provide a novel approach for selection of molecular targets.” JOURNAL OF CLINICAL ONCOLOGY, vol. 23, no. 16, AMER SOC CLINICAL ONCOLOGY, 2005, pp. 626S-626S.
Petersen RP, Bild A, Dressman H, Joshi MBM, Conlon DH, West M, Nevins JR, Harpole DH. Gene expression signatures for prognosis in NSCLC, coupled with signatures of oncogenic pathway deregulation, provide a novel approach for selection of molecular targets. JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY; 2005. p. 626S-626S.
Published In
JOURNAL OF CLINICAL ONCOLOGY
EISSN
1527-7755
ISSN
0732-183X
Publication Date
June 1, 2005
Volume
23
Issue
16
Start / End Page
626S / 626S
Location
Orlando, FL
Publisher
AMER SOC CLINICAL ONCOLOGY
Conference Name
41st Annual Meeting of the American-Society-of-Clinical-Oncology
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences